Sign Up Today and Learn More About Help Therapeutics Stock
Invest in or calculate the value of your shares in Help Therapeutics or other pre-IPO companies through EquityZen's platform.
Help Therapeutics Stock
Developing Cell Therapies for Degenerative Diseases.
About Help Therapeutics Stock
Founded
2016
Industries
Travel and Tourism, Manufacturing, Space
Help Therapeutics Press Mentions
Stay in the know about the latest news on Help Therapeutics
From Follower to Force: China's Biotech Sector Enters the Global Clinical Mainstream
morningstar • Dec 26, 2025
From Follower to Force: China's Biotech Sector Enters the Global Clinical Mainstream
prnewswire • Dec 26, 2025
HELP Therapeutics and China Resources Sanjiu Announce Strategic Partnership to Co-Develop and Commercialize HiCM-188 for Advanced Heart Failure in Mainland China
en • Jun 17, 2025
HELP Therapeutics and China Resources Sanjiu Announce Strategic Partnership to Co-Develop and Commercialize HiCM-188 for Advanced Heart Failure in Mainland China
biospace • Jun 17, 2025
HELP Therapeutics and China Resources Sanjiu Announce Strategic Partnership to Co-Develop and Commercialize HiCM-188 for Advanced Heart Failure
en • Jun 16, 2025
Help Therapeutics Management
Leadership team at Help Therapeutics
Founder & CEO
Jiaxian Wang
Join now and verify your accreditation status to gain access to:
- Help Therapeutics Current Valuation
- Help Therapeutics Stock Price
- Help Therapeutics Management
- Available deals in Help Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Help Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Help Therapeutics Revenue and Financials
- Help Therapeutics Highlights
- Help Therapeutics Business Model
- Help Therapeutics Risk Factors
- Help Therapeutics Research Report from SACRA Research
Trading Help Therapeutics Stock
How to invest in Help Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Help Therapeutics through EquityZen funds. These investments are made available by existing Help Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Help Therapeutics stock?
Shareholders can sell their Help Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 410K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 51K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."